Perspective Therapeutics Enters Clinical Trial Collaboration With Merck To Combine Its PSV359 With Keytruda Under An Amendment To Ongoing Phase 1/2A Study Of PSV359 In Patients With Certain Types Of Non-Small Cell Lung Cancer And Colorectal Cancer
In brief
Perspective and Merck are teaming up to test a promising combo of radiopharmaceutical and immunotherapy in solid tumors, potentially opening a new therapeutic avenue.